Related Experiment Videos

Heparin reduces proliferative angiopathy following subarachnoid hemorrhage in cats

Insights

Systemic heparin reduced proliferative angiopathy after subarachnoid hemorrhage (SAH) in cats. This suggests heparin may inhibit platelet-derived growth factors contributing to cerebral artery damage following SAH.

Area of Science:

  • Neurology
  • Vascular Biology
  • Pathology

Background:

  • Subarachnoid hemorrhage (SAH) can lead to secondary brain injury.
  • Proliferative angiopathy is a pathological response observed in cerebral arteries after SAH.
  • Platelet activation and aggregation are implicated in the vascular response to SAH.

Purpose of the Study:

  • To investigate the effect of systemic heparin on the development of proliferative angiopathy following induced SAH in a feline model.
  • To explore the potential role of platelet-derived growth factors in SAH-induced vascular remodeling.

Main Methods:

  • Subarachnoid hemorrhage was induced in cats by rupturing the middle cerebral artery (MCA).
  • Cats were either untreated or received systemic heparin treatment.
  • Vascular changes in the MCAs were assessed 16 days post-SAH.

Main Results:

  • Untreated cats developed widespread proliferative angiopathy in both MCAs by day 16.
  • Heparin treatment significantly reduced pathological changes in the ruptured MCA.
  • Proliferative angiopathy was absent in the contralateral MCA of heparin-treated cats.
  • Platelet adherence to the subintimal surface of cerebral arteries was observed post-SAH.

Conclusions:

  • Systemic heparin administration effectively mitigates proliferative angiopathy following SAH in cats.
  • Platelet-derived growth factors released from intimal platelet aggregates are suggested as a stimulus for angiopathy.
  • Heparin's inhibitory effect on these platelet factors may prevent SAH-induced vascular pathology.

Related Concept Videos